These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7623959)

  • 1. Pharmacological evidence for the involvement of sigma sites in DTG-induced contralateral circling in rats.
    Bastianetto S; Perrault G; Sanger DJ
    Neuropharmacology; 1995 Jan; 34(1):107-14. PubMed ID: 7623959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DTG-induced circling behaviour in rats may involve the interaction between sigma sites and nigro-striatal dopaminergic pathways.
    Bastianetto S; Rouquier L; Perrault G; Sanger DJ
    Neuropharmacology; 1995 Mar; 34(3):281-7. PubMed ID: 7630482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ
    Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats.
    Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
    Eur J Pharmacol; 1996 Dec; 318(2-3):205-11. PubMed ID: 9016907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective sigma ligands on duodenal alkaline secretion in the rat.
    Pascaud X; Defaux JP; Rozé C; Junien JL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1354-9. PubMed ID: 2175804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
    Brent PJ
    Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of haloperidol-sensitive sigma-sites in antitussive effects.
    Kamei J; Iwamoto Y; Kawashima N; Hitosugi H; Misawa M; Kasuya Y
    Eur J Pharmacol; 1992 Nov; 224(1):39-43. PubMed ID: 1451741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
    Larson AA; Sun X
    Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sigma receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex.
    Roth JE; Franklin PH; Murray TF
    Eur J Pharmacol; 1993 May; 236(2):327-31. PubMed ID: 8319759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subcutaneous and intracerebroventricular administration of the sigma receptor ligand 1,3-Di-o-tolylguanidine on body temperature in the rat: interactions with BMY 14802 and rimcazole.
    Bejanian M; Pechnick RN; Bova MP; George R
    J Pharmacol Exp Ther; 1991 Jul; 258(1):88-93. PubMed ID: 1677044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites.
    Brent PJ; Chahl LA
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):23-32. PubMed ID: 8097127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1,3-di-o-tolylguanidine (DTG), rimcazole and EMD 57445, the sigma receptor ligands, in the forced swimming test.
    Skuza G; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):329-35. PubMed ID: 9566032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between modulation of the cerebellorubrospinal system in the in vitro turtle brain and changes in motor behavior in rats: effects of novel sigma ligands.
    Matsumoto RR; Bowen WD; de Costa BR; Houk JC
    Brain Res Bull; 1999 Mar; 48(5):497-508. PubMed ID: 10372510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociception following 1,3,-di-o-tolylguanidine, a selective sigma receptor ligand.
    Kest B; Mogil JS; Sternberg WF; Pechnick RN; Liebeskind JC
    Pharmacol Biochem Behav; 1995 Apr; 50(4):587-92. PubMed ID: 7617705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
    Singh L; Wong EH; Kesingland AC; Tricklebank MD
    Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the NH2-terminus of substance P modulates N-methyl-D-aspartate-induced activity by an action involving sigma receptors.
    Hornfeldt CS; Kitto KF; Larson AA
    Eur J Pharmacol; 1996 Jun; 306(1-3):15-22. PubMed ID: 8813610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of sigma receptor ligands.
    Weiser SD; Patrick SL; Mascarella SW; Downing-Park J; Bai X; Carroll FI; Walker JM; Patrick RL
    Eur J Pharmacol; 1995 Feb; 275(1):1-7. PubMed ID: 7774655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.
    Beart PM; O'Shea RD; Manallack DT
    J Neurochem; 1989 Sep; 53(3):779-88. PubMed ID: 2569504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats.
    Scalzo FM; Burge LJ
    Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.